The International Chemical Biology Society (ICBS) and the Future Science Group have announced a new collaboration, with the journal Future Medicinal Chemistry becoming an official partner publication of the Society.
Following an announcement at the 6th Official Conference of the ICBS, in Shanghai, China (October 17–20), Future Medicinal Chemistry and the ICBS will work together closely to publish cutting-edge content on chemical biology, and to provide a variety of benefits to members of the ICBS.
The journal will welcome members of the ICBS onto their highly respected Editorial Board, allowing them to work together to ensure that the most relevant and interesting content is published in the field of chemical biology, including a number of themed issues each year. New members will join existing Senior Editor Professor Jonathan Baell (Monash University, Australia), a member of the ICBS Board of Directors, who was instrumental in initiating the partnership together with Professor Zaneta Nikolovska-Coleska (University of Michigan, USA) and other members of the ICBS Board of Directors.
ICBS members will receive a variety of benefits from the publisher, including discounted journal subscriptions and reduced fees for the journal's optional Open Access service. In addition, members of the ICBS will benefit from the unique networking and collaboration opportunities provided by the journal's partner website MedChemNet.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
